Call for Proposals for Applied Healthcare Innovation 2026

Hadasit, Hadassah’s innovation and entrepreneurship company, in collaboration with the Hadassah Research Fund, invites physicians and researchers to submit proposals for applied research funding under the Hadasit 2026 JumpStart Program.

The program is designed to accelerate the translation of innovative clinical and scientific ideas into viable healthcare solutions. Selected projects will benefit from staged funding, professional scientific, technology development support, and direct connections to the healthcare innovation ecosystem.

Program Objectives

Hadassah JumpStart supports the development of innovative healthcare technologies, including medical devices (Primarily), AI solutions, diagnostics, and novel bio-therapeutic approaches (including Bio-convergence). The program provides milestone-based funding, professional guidance, and access to relevant stakeholders for projects selected through a competitive evaluation process.

Priority shall be given to projects that demonstrate one or more of the following:

• Medical devices & Bio-Convergence technologies demonstrating initial results in human subjects by the end of the funding period.
• AI & Digital health
• Early-career investigators (From two years before tenure to three years after). 

Key Evaluation Criteria

Projects will be evaluated based on:

• Clear pathway to develop a defined translational technology with a well-articulated use case.
• Strong and demonstrated translational and clinical implementation rationale, including:
  • Clearly defined unmet clinical need
  • Understanding of clinical and scientific gap
  • Clear value proposition and differentiation from existing solutions
• Commitment and capability of the principal investigator to lead the project and fulfill reporting requirements.

Collaborative projects with external institutions may be approved, provided that the partner can independently fund its share of the project or commits to reimbursing Hadassah at a later stage, and that intellectual property arrangements are formally agreed between Hadasit and the partner’s commercialization entity. The above does not apply to service providers or subcontractors.

This year’s call includes two funding tracks:

• Track 1 – JumpStart Open
  Multi-stage funding (Pre-Seed, Seed, Post-Seed) for projects across all scientific and technological fields (up to 170,000 NIS).
• Track 2 – JumpStart Focus
  Advanced-stage funding (up to 300,000 NIS) for projects in the following focus areas:
  Breast Cancer, Genetic Diseases, and Cardiovascular Diseases.

Click here to download Full Description of the Jumpstart Call For Proposal 

Application documents:

Click here to download Executive Summary

Click here to download Pitch Deck Template

Submission & Evaluation Process for both Funding Tracks

Applications must be submitted in English using the provided application materials (presentation template and executive summary form). Submission should be sent by email to: infohadasit@hadassah.org.il no later than May 17, 2026 at 13:00.

Projects will be reviewed by an investment committee composed of external industry professionals with experience in biomedical innovation, entrepreneurship, and investment, alongside representatives from Hadassah and Hadasit.

Shortlisted applicants will be invited to present to the Investment Committee and prepare a 15 minutes presentation addressing:

• Research team
• Technology under development
• Clinical landscape, size, and environment
• Unique advantages and differentiation
• Progress to date
• Development plan, budget, and measurable milestones

Guidance and Contact Information

For consultation regarding eligibility or appropriate funding track:

Medical Devices and Digital Health
Ariel Shrem
ashrem@hadassah.org.il | +972-58-762-2811

Pharma and Diagnostics
Nadav Askari
nadavask@hadassah.org.il | +972-52-4044-876